These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1331413)

  • 21. Dopamine displays an identical apparent affinity towards functional dopamine D1 and D2 receptors in rat striatal slices: possible implications for the regulatory role of D2 receptors.
    Schoffelmeer AN; Hogenboom F; Mulder AH; Ronken E; Stoof JC; Drukarch B
    Synapse; 1994 Jul; 17(3):190-5. PubMed ID: 7974202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [3H]-quinelorane binds to D2 and D3 dopamine receptors in the rat brain.
    Gackenheimer SL; Schaus JM; Gehlert DR
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1558-65. PubMed ID: 7562534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [3H]Pramipexole: a selective radioligand for the high affinity dopamine D2 receptor in bovine striatal membranes.
    Ohnmacht U; Tränkle C; Mohr K; Gmeiner P
    Pharmazie; 1999 Apr; 54(4):294-7. PubMed ID: 10234741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
    Hancock AA; Marsh CL
    Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paradoxical regulation of dopamine receptors in transfected 293 cells.
    Filtz TM; Artymyshyn RP; Guan W; Molinoff PB
    Mol Pharmacol; 1993 Aug; 44(2):371-9. PubMed ID: 8102783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurotensin modulates the binding characteristics of dopamine D2 receptors in rat striatal membranes also following treatment with toluene.
    von Euler G; Fuxe K; Benfenati F; Hansson T; Agnati LF; Gustafsson JA
    Acta Physiol Scand; 1989 Apr; 135(4):443-8. PubMed ID: 2525310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of high-affinity dopamine D2 receptors and modulation of affinity states by guanine nucleotides in cholate-solubilized bovine striatal preparations.
    Kazmi SM; Ramwani J; Srivastava LK; Rajakumar G; Ross GM; Cullen M; Mishra RK
    J Neurochem; 1986 Nov; 47(5):1493-502. PubMed ID: 3760872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiosynthesis and ex vivo evaluation of (R)-(-)-2-chloro-N-[1-11C-propyl]n-propylnorapomorphine.
    Palner M; McCormick P; Gillings N; Begtrup M; Wilson AA; Knudsen GM
    Nucl Med Biol; 2010 Jan; 37(1):35-40. PubMed ID: 20122666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopamine receptor binding in bovine intermediate lobe pituitary membranes.
    Sibley DR; Creese I
    Endocrinology; 1980 Nov; 107(5):1405-9. PubMed ID: 7428676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo labelling of rat brain dopamine D-2 receptors. Stereoselective blockade by the D-2 antagonist raclopride and its enantiomer of 3H-spiperone, 3H-N,N-propylnorapomorphine and 3H-raclopride binding in the rat brain.
    Köhler C; Karlsson-Boethius G
    J Neural Transm; 1988; 73(2):87-100. PubMed ID: 2974879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Possible involvement of G-proteins in the regulation of striatal dopamine D2 receptor affinity by cholecystokinin octapeptide.
    Li XM; Jansson A; Finnman UB; Agnati LF; Fuxe K
    Neurosci Lett; 1997 Jun; 228(3):171-4. PubMed ID: 9218635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation by estradiol and progesterone of the GTP effect on striatal D-2 dopamine receptors.
    Lévesque D; Di Paolo T
    Biochem Pharmacol; 1993 Feb; 45(3):723-33. PubMed ID: 8095140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural differences between dopamine D2 receptors present in a rat pituitary adenoma and in transplantable rat pituitary tumors 7315a and MtTW15.
    Bouvier C; Lagacé G; Potier M; Collu R
    J Neurochem; 1990 Mar; 54(3):815-22. PubMed ID: 1968089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional modifications of the coupling of solubilized dopamine D2 receptors to guanine-nucleotide-binding proteins.
    Kazmi SM; Srivastava LK; Mishra RK
    Biol Signals; 1992; 1(4):194-207. PubMed ID: 1364039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopamine receptor binding sites in the rat superior colliculus.
    Chivers JK; Hall MD; Kelly E; Jenner P; Marsden CD
    J Pharm Pharmacol; 1984 Jul; 36(7):484-8. PubMed ID: 6146700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Agonist and receptor binding properties of adrenocorticotropin peptides using the cloned mouse adrenocorticotropin receptor expressed in a stably transfected HeLa cell line.
    Kapas S; Cammas FM; Hinson JP; Clark AJ
    Endocrinology; 1996 Aug; 137(8):3291-4. PubMed ID: 8754753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurotensin decreases the affinity of dopamine D2 agonist binding by a G protein-independent mechanism.
    von Euler G; van der Ploeg I; Fredholm BB; Fuxe K
    J Neurochem; 1991 Jan; 56(1):178-83. PubMed ID: 1824779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of chronic treatment with morphine on the binding of 3H-N-n-propylnorapomorphine to striatal membranes of rats: influence of prolyl-leucyl-glycinamide.
    Das S; Bhargava HN
    Pharmacology; 1985; 31(5):241-7. PubMed ID: 2866551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of the D2short dopamine receptor with G proteins: analysis of receptor/G protein selectivity.
    Nickolls SA; Strange PG
    Biochem Pharmacol; 2003 Apr; 65(7):1139-50. PubMed ID: 12663049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic ACTH treatment increases striatal dopamine D-2 receptor binding in developing rat brain.
    Chiriboga CA; Pranzatelli MR; De Vivo DC
    Brain Dev; 1989; 11(3):197-200. PubMed ID: 2546461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.